131 related articles for article (PubMed ID: 11842257)
21. Paramyxovirus fusion (F) protein: a conformational change on cleavage activation.
Dutch RE; Hagglund RN; Nagel MA; Paterson RG; Lamb RA
Virology; 2001 Mar; 281(1):138-50. PubMed ID: 11222104
[TBL] [Abstract][Full Text] [Related]
22. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
23. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
[TBL] [Abstract][Full Text] [Related]
24. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion.
Chen L; Gorman JJ; McKimm-Breschkin J; Lawrence LJ; Tulloch PA; Smith BJ; Colman PM; Lawrence MC
Structure; 2001 Mar; 9(3):255-66. PubMed ID: 11286892
[TBL] [Abstract][Full Text] [Related]
25. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
Ghosh JK; Shai Y
J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
[TBL] [Abstract][Full Text] [Related]
26. Interacting domains of the HN and F proteins of newcastle disease virus.
Gravel KA; Morrison TG
J Virol; 2003 Oct; 77(20):11040-9. PubMed ID: 14512552
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.
McGinnes LW; Sergel T; Chen H; Hamo L; Schwertz S; Li D; Morrison TG
Virology; 2001 Oct; 289(2):343-52. PubMed ID: 11689056
[TBL] [Abstract][Full Text] [Related]
28. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.
Young JK; Hicks RP; Wright GE; Morrison TG
Virology; 1997 Nov; 238(2):291-304. PubMed ID: 9400602
[TBL] [Abstract][Full Text] [Related]
29. Structure of the Newcastle disease virus F protein in the post-fusion conformation.
Swanson K; Wen X; Leser GP; Paterson RG; Lamb RA; Jardetzky TS
Virology; 2010 Jul; 402(2):372-9. PubMed ID: 20439109
[TBL] [Abstract][Full Text] [Related]
30. Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies.
Mzoughi O; Gaston F; Granados GC; Lakhdar-Ghazal F; Giralt E; Bahraoui E
ChemMedChem; 2010 Nov; 5(11):1907-18. PubMed ID: 20922745
[TBL] [Abstract][Full Text] [Related]
31. Characterization of BIV Env core: implication for mechanism of BIV-mediated cell fusion.
Li S; Zhu J; Peng Y; Cui S; Wang C; Gao GF; Tien P
Biochem Biophys Res Commun; 2005 Apr; 329(2):603-9. PubMed ID: 15737628
[TBL] [Abstract][Full Text] [Related]
32. Biochemical, biophysical and preliminary X-ray crystallographic analyses of the fusion core of Sendai virus F protein.
Wang X; Xu Y; Cole DK; Lou Z; Liu Y; Rao Z; Wang M; Gao GF
Acta Crystallogr D Biol Crystallogr; 2004 Sep; 60(Pt 9):1632-5. PubMed ID: 15333939
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.
Sergel TA; McGinnes LW; Morrison TG
J Virol; 2001 Sep; 75(17):7934-43. PubMed ID: 11483738
[TBL] [Abstract][Full Text] [Related]
34. Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein.
Roymans D; De Bondt HL; Arnoult E; Geluykens P; Gevers T; Van Ginderen M; Verheyen N; Kim H; Willebrords R; Bonfanti JF; Bruinzeel W; Cummings MD; van Vlijmen H; Andries K
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):308-13. PubMed ID: 19966279
[TBL] [Abstract][Full Text] [Related]
35. Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion.
Ghosh JK; Peisajovich SG; Ovadia M; Shai Y
J Biol Chem; 1998 Oct; 273(42):27182-90. PubMed ID: 9765238
[TBL] [Abstract][Full Text] [Related]
36. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
37. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
[TBL] [Abstract][Full Text] [Related]
38. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
Supekar VM; Bruckmann C; Ingallinella P; Bianchi E; Pessi A; Carfí A
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):17958-63. PubMed ID: 15604146
[TBL] [Abstract][Full Text] [Related]
39. Rational design of highly potent HIV-1 fusion inhibitory proteins: implication for developing antiviral therapeutics.
Ni L; Gao GF; Tien P
Biochem Biophys Res Commun; 2005 Jul; 332(3):831-6. PubMed ID: 15913557
[TBL] [Abstract][Full Text] [Related]
40. Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation.
Yunus AS; Jackson TP; Crisafi K; Burimski I; Kilgore NR; Zoumplis D; Allaway GP; Wild CT; Salzwedel K
Virology; 2010 Jan; 396(2):226-37. PubMed ID: 19922971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
